Venus Medtech (Hangzhou) Inc.

SEHK:2500 Rapporto sulle azioni

Cap. di mercato: HK$2.5b

Venus Medtech (Hangzhou) Performance dei guadagni passati

Il passato criteri di controllo 0/6

Gli utili di Venus Medtech (Hangzhou) sono diminuiti a un tasso medio annuo di -42.6%, mentre il settore Medical Equipment ha visto gli utili crescere a un tasso medio annuo di 14.7%. I ricavi sono cresciuti crescere a un tasso medio annuo di 16.9%.

Informazioni chiave

-42.6%

Tasso di crescita degli utili

-34.9%

Tasso di crescita dell'EPS

Medical Equipment Crescita del settore13.7%
Tasso di crescita dei ricavi16.9%
Rendimento del capitale proprio-37.6%
Margine netto-267.2%
Ultimo aggiornamento sui guadagni30 Jun 2023

Aggiornamenti sulle prestazioni recenti

Recent updates

Is Venus Medtech (Hangzhou) (HKG:2500) A Risky Investment?

Oct 05
Is Venus Medtech (Hangzhou) (HKG:2500) A Risky Investment?

Is Venus Medtech (Hangzhou) (HKG:2500) Using Debt In A Risky Way?

May 29
Is Venus Medtech (Hangzhou) (HKG:2500) Using Debt In A Risky Way?

What Venus Medtech (Hangzhou) Inc.'s (HKG:2500) P/S Is Not Telling You

May 11
What Venus Medtech (Hangzhou) Inc.'s (HKG:2500) P/S Is Not Telling You

Time To Worry? Analysts Are Downgrading Their Venus Medtech (Hangzhou) Inc. (HKG:2500) Outlook

Apr 07
Time To Worry? Analysts Are Downgrading Their Venus Medtech (Hangzhou) Inc. (HKG:2500) Outlook

Is Venus Medtech (Hangzhou) (HKG:2500) Weighed On By Its Debt Load?

Oct 12
Is Venus Medtech (Hangzhou) (HKG:2500) Weighed On By Its Debt Load?

Need To Know: Analysts Just Made A Substantial Cut To Their Venus Medtech (Hangzhou) Inc. (HKG:2500) Estimates

Sep 04
Need To Know: Analysts Just Made A Substantial Cut To Their Venus Medtech (Hangzhou) Inc. (HKG:2500) Estimates

We're Not Very Worried About Venus Medtech (Hangzhou)'s (HKG:2500) Cash Burn Rate

Jul 28
We're Not Very Worried About Venus Medtech (Hangzhou)'s (HKG:2500) Cash Burn Rate

Companies Like Venus Medtech (Hangzhou) (HKG:2500) Are In A Position To Invest In Growth

Mar 29
Companies Like Venus Medtech (Hangzhou) (HKG:2500) Are In A Position To Invest In Growth

Are Investors Undervaluing Venus Medtech (Hangzhou) Inc. (HKG:2500) By 43%?

Jan 09
Are Investors Undervaluing Venus Medtech (Hangzhou) Inc. (HKG:2500) By 43%?

Here's Why We're Not At All Concerned With Venus Medtech (Hangzhou)'s (HKG:2500) Cash Burn Situation

Dec 01
Here's Why We're Not At All Concerned With Venus Medtech (Hangzhou)'s (HKG:2500) Cash Burn Situation

We're Interested To See How Venus Medtech (Hangzhou) (HKG:2500) Uses Its Cash Hoard To Grow

Aug 16
We're Interested To See How Venus Medtech (Hangzhou) (HKG:2500) Uses Its Cash Hoard To Grow

A Look At The Intrinsic Value Of Venus Medtech (Hangzhou) Inc. (HKG:2500)

Jul 12
A Look At The Intrinsic Value Of Venus Medtech (Hangzhou) Inc. (HKG:2500)

Companies Like Venus Medtech (Hangzhou) (HKG:2500) Can Afford To Invest In Growth

Apr 26
Companies Like Venus Medtech (Hangzhou) (HKG:2500) Can Afford To Invest In Growth

Analysts Have Just Cut Their Venus Medtech (Hangzhou) Inc. (HKG:2500) Revenue Estimates By 28%

Apr 05
Analysts Have Just Cut Their Venus Medtech (Hangzhou) Inc. (HKG:2500) Revenue Estimates By 28%

Venus Medtech (Hangzhou) Inc. (HKG:2500) Shares Could Be 23% Above Their Intrinsic Value Estimate

Mar 07
Venus Medtech (Hangzhou) Inc. (HKG:2500) Shares Could Be 23% Above Their Intrinsic Value Estimate

What Type Of Shareholders Make Up Venus Medtech (Hangzhou) Inc.'s (HKG:2500) Share Registry?

Feb 14
What Type Of Shareholders Make Up Venus Medtech (Hangzhou) Inc.'s (HKG:2500) Share Registry?

Venus Medtech (Hangzhou) Inc. (HKG:2500) Is About To Turn The Corner

Jan 19
Venus Medtech (Hangzhou) Inc. (HKG:2500) Is About To Turn The Corner

Have Insiders Been Selling Venus Medtech (Hangzhou) Inc. (HKG:2500) Shares?

Dec 29
Have Insiders Been Selling Venus Medtech (Hangzhou) Inc. (HKG:2500) Shares?

Have Insiders Sold Venus Medtech (Hangzhou) Inc. (HKG:2500) Shares Recently?

Dec 29
Have Insiders Sold Venus Medtech (Hangzhou) Inc. (HKG:2500) Shares Recently?

Can You Imagine How Venus Medtech (Hangzhou)'s (HKG:2500) Shareholders Feel About The 78% Share Price Increase?

Dec 08
Can You Imagine How Venus Medtech (Hangzhou)'s (HKG:2500) Shareholders Feel About The 78% Share Price Increase?

Ripartizione dei ricavi e delle spese

Come Venus Medtech (Hangzhou) guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

SEHK:2500 Ricavi, spese e utili (CNY Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Jun 23452-1,208500602
31 Mar 23429-1,133468565
31 Dec 22406-1,058437527
30 Sep 22397-759411451
30 Jun 22387-461382374
31 Mar 22401-417364316
31 Dec 21416-374345258
30 Sep 21415-313320231
30 Jun 21413-252295204
31 Mar 21345-217267186
31 Dec 20276-182239167
30 Sep 20252-210247165
30 Jun 20228-238256163
31 Mar 20231-310289182
31 Dec 19233-381322201
31 Dec 18115-300291105
31 Dec 1718-15756117

Guadagni di qualità: 2500 al momento non è redditizia.

Margine di profitto in crescita: 2500 al momento non è redditizia.


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: 2500 non è redditizia e le perdite sono aumentate negli ultimi 5 anni a un tasso pari a 42.6% all'anno.

Accelerare la crescita: Impossibile confrontare la crescita degli utili di 2500 nell'ultimo anno con la sua media quinquennale poiché al momento non è redditizia

Guadagni vs Settore: 2500 non è redditizia, il che rende difficile confrontare la crescita dei suoi utili dell'anno passato con il settore Medical Equipment ( -4.3% ).


Rendimento del capitale proprio

ROE elevato: 2500 ha un Return on Equity negativo ( -37.59% ), in quanto al momento non è redditizio.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate